Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Bristol-Myers Squibb
Bristol-Myers Squibb
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Columbia University
Ipsen
Ascentage Pharma Group Inc.
MacroGenics
Masonic Cancer Center, University of Minnesota
Valerio Therapeutics
Valerio Therapeutics
Astellas Pharma Inc